Bids are Invited For Chlorpheniramine Maleate + Dextromethorphan + Phenylephrine Tablets (V2),Nitrofurantoin Tablet,Cape in MEERUT, UTTAR PRADESH

The eligibility requirements for this tender include being a registered entity within the pharmaceutical sector, possessing necessary certifications, and adhering to manufacturing standards for the specific medications listed. Bidders should demonstrate compliance with quality assurance and regulatory requirements as mandated by the Department of Military Affairs.

Bidders must provide specific certifications confirming compliance with relevant pharmaceutical manufacturing standards. These certifications may include Good Manufacturing Practices (GMP), product safety testing certifications, and other documentation proving the quality and efficacy of the medications being offered.

To register for the tender, vendors must create an account on the governmental electronic procurement platform. Following account creation, they can access the tender documents, submit their bid proposals, and navigate through the submission process in accordance to the guidelines provided.

Submissions are generally accepted in digital formats that are specified within the tender documentation. It is advisable for bidders to check specific guidelines for formatting, which ensures that all necessary documents are submitted correctly and are compatible with the platform requirements.

Vendors must provide details on the technical specifications of the pharmaceuticals they intend to supply, specifically focusing on quality, safety, and efficacy standards. This includes compliance with established pharmacopeias and any additional specifications outlined in the tender.

Yes, bidders are required to comply with stringent quality standards set by relevant drug regulatory authorities. This encompasses ensuring that all pharmaceuticals meet required specifications for active ingredients, formulation, packaging, and labeling as per industry norms and guidelines.

Compliance requirements include adherence to all applicable laws and regulations governing pharmaceutical products, including those related to manufacturing, distribution, and retail. Bidders must demonstrate their capability to meet these legal obligations in their submissions.

Yes, an Earnest Money Deposit (EMD) may be required as part of the bid submission process. Details regarding the amount and submission procedure for EMD will be outlined in the associated tender documents.

Performance security requirements mandate that successful bidders provide a performance guarantee, which acts as a financial safeguard ensuring contract compliance. Specifics regarding the amount and form of performance security will be provided in the tender documentation.

Payment terms are typically detailed within the tender document, encompassing payment conditions upon successful delivery, acceptance of products, and adherence to contractual obligations. Vendors should review these terms closely to understand their cash flow implications.

Price evaluation considers several factors including, but not limited to, the competitiveness of the proposed pricing, adherence to quality standards, and compliance with specifications set forth in the tender. This holistic analysis ensures that the best value is secured for the government.

Key timelines and deadlines for submission will be explicitly stated in the tender documentation. Suppliers are advised to adhere closely to these timelines to ensure eligibility for consideration.

The evaluation and selection process involves a thorough assessment of each submitted bid based on technical merits, compliance with specifications, financial viability, and overall value proposition. The specific criteria for evaluation are detailed within the tender documents.

Vendors will typically receive notifications regarding the results of the tender process through the electronic procurement platform used for submission. Notifications will outline the outcomes of the evaluation process and any necessary next steps.

Micro, Small, and Medium Enterprises (MSEs) stand to gain from enhanced opportunities for participation in this tender, including potential relaxations in eligibility criteria and additional support aimed at fostering competition and innovation.

Yes, there are provisions to accommodate startups, encouraging them to participate by relaxing certain eligibility requirements or offering support mechanisms designed to enhance their chances of successfully bidding.

This tender supports the ‘Make in India’ initiative by prioritizing domestic manufacturing and encouraging local entrepreneurship within the pharmaceutical sector, thus promoting self-reliance and indigenous production capabilities.

Yes, procurement rules typically stress the importance of local content as part of the bidding process, encouraging suppliers to source materials locally and contribute to the regional economy while ensuring compliance with applicable guidelines.